| 581 | BENEN, SANDRA E.DURHAM, NC · 27709 | DIRECTOR SGA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 582 | HOWELL, WILLIAM BDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 583 | HILL, WANDAPHILADELPHIA, PA · 19112 | GAPP SPECIAL PROJECTS - SECONDMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 584 | MARTIN, LISAPHILADELPHIA, PA · 19112 | CHIEF PROCUREMENT OFFICER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 585 | BADON, TY ALLENDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 586 | MOTT, AMANDA GRASHOFDURHAM, NC · 27701 | ACCESS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 587 | BOBBA, DURGA PRASADPHILADELPHIA, PA · 19104 | VP, VACCINE COMMERCIALISATION LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 588 | CLOUD, MONICA RWASHINGTON, DC · 20004 | DIRECTOR FEDERAL GOVERNMENT RELATIONS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 589 | BAGCHI, INDRANILCOLLEGEVILLE, PA · 19426 | VP, GLOBAL PRICING & MARKET ACCESS HEA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 590 | FINNEGAN, CANDICE CINNAMONPHILADELPHIA, PA · 19112 | HEAD, STATE GOVERNMENT AFFAIRS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 591 | RIVIERE, JESSICAPHILADELPHIA, PA · 19104 | U.S. PATIENT ADVOCACY & ENGAGEMENT ENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-06 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 592 | ENDRES, JENNEAN MARIEPHILADELPHIA, PA · 19104 | LAWYER/ATTORNEY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 593 | FOX, JENNIFER WILLISDURHAM, NC · 27709 | MARKET ACCESS FIELD VICE PRESIDENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 594 | MADAUSS, KEVIN PATRICKCOLLEGEVILLE, PA · 19426 | GENERAL PROJECT MANAGEMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 595 | LEWIS, ANTON DDURHAM, NC · 27709 | FVP, MARKET ACCESS ACCOUNT INTEGRATION · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 596 | THEVENET, PHILIP M.WASHINGTON, DC · 20004 | DIRECTOR, GOVERNMENT RELATIONS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 597 | BENEN, SANDRA E.DURHAM, NC · 27709 | DIRECTOR SGA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 598 | HOWELL, WILLIAM BDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 599 | HILL, WANDAPHILADELPHIA, PA · 19112 | GAPP SPECIAL PROJECTS - SECONDMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 600 | MARTIN, LISAPHILADELPHIA, PA · 19112 | CHIEF PROCUREMENT OFFICER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |